Back
Verrica Pharmaceuticals Vs. Argan Industry Stock Comparison
Sell
20
VRCA
Verrica Pharmaceuticals
Last Price:
$0.46
Seasonality Move:
-14.97%
Buy
73
AGX
Argan
Last Price:
$153.18
Seasonality Move:
7.58%
Sell
20
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
-
The current Verrica Pharmaceuticals [VRCA] share price is $0.46. The Score for VRCA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
VRCA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $0.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight selling pressure.
VRCA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 44.55 | Sell |
Chaikin Money Flow: | -72030 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.43 - 0.53) | Sell |
Bollinger Bands (100): | (0.49 - 0.83) | Sell |
AGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.37 | Buy |
Relative Strength Index (14 RSI): | 60.61 | Buy |
Chaikin Money Flow: | 150278 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (126.29 - 148.21) | Buy |
Bollinger Bands (100): | (125.33 - 157.33) | Buy |
VRCA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.47 | Sell |
20-day SMA: | 0.49 | Sell |
50-day SMA: | 0.56 | Sell |
200-day SMA: | 1.83 | Sell |
8-day EMA: | 0.47 | Sell |
20-day EMA: | 0.49 | Sell |
50-day EMA: | 0.56 | Sell |
200-day EMA: | 1.83 | Sell |
AGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 144.6 | Buy |
20-day SMA: | 140.01 | Buy |
50-day SMA: | 131.9 | Buy |
200-day SMA: | 121.55 | Buy |
8-day EMA: | 147.22 | Buy |
20-day EMA: | 141.16 | Buy |
50-day EMA: | 137.28 | Buy |
200-day EMA: | 121.39 | Buy |
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.12 per share.
Argan Earnings Growth & AGX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.36 per share, an increase next quarter of $0.13 per share, an increase this year of $2.73 per share, and an increase next year of $0.72 per share.
Verrica Pharmaceuticals Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Argan Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |